👤 Zhang, Xue

Keywords

🔗 2019-nCoV (257) 🔗 () 🔗 drugs (217) 🔗 molecular docking (6) 🔗 () 🔗 network pharmacology (2) 🔗 pneumonia (602) 🔗 Wuhan Coronavirus (2) 🔗 syndrome coronavirus (1074) 🔗 novel coronavirus (684) 🔗 respiratory syndrome (2004) 🔗 acute respiratory (1734) 🔗 severe acute (1373) 🔗 public health (392) 🔗 high mortality (78)

Articles (2)

In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus.
👤 Zhang, Deng-Hai 👤 Wu, Kun-Lun 👤 Zhang, Xue 👤 Deng, Sheng-Qiong 👤 Peng, Bin ⏰ 2020 📚 J Integr Med
Glycopeptide antibiotics potently inhibit cathepsin l in the late endosome/lysosome and block the entry of ebola virus, middle east respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV)
👤 Zhou, Nan 👤 Pan, Ting 👤 Zhang, Junsong 👤 Li, Qianwen 👤 Zhang, Xue 👤 Bai, Chuan 👤 Huang, Feng 👤 Peng, Tao 👤 Zhang, Jianhua 👤 Liu, Chao 👤 Tao, Liang 👤 Zhang, Hui ⏰ 2016 📚 Journal of Biological Chemistry